CGEM
Cullinan Therapeutics
$15.56
+$0.72 (+4.85%)Oct 28, 2026
Key metrics
The numbers that frame CGEM today
- Market cap
- $1.00B
- ROIC
- -67.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $6.73
- 52wk High
- $23.19
Growth
Revenue and earnings trend for CGEM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CGEM
Is Cullinan Therapeutics a good buy?
Hold. Cullinan Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Cullinan Therapeutics is selling at a very high price.
What is the market capitalization of CGEM?
Cullinan Therapeutics's market capitalization is $1.00B.
What is the 52-week high for CGEM stock?
The 52-week high for Cullinan Therapeutics is $23.19. The current close of $15.56 is 32.9% below that high.
What is the 52-week low for CGEM stock?
The 52-week low for Cullinan Therapeutics is $6.73. The current close of $15.56 is 131.1% above that low.
Does CGEM stock pay dividends?
Cullinan Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CGEM?
Cullinan Therapeutics's Debt / Equity ratio is 0.01.